Abbott Laboratories (ABT) ist ein börsennotiertes Unternehmen im Gesundheitswesen Sektor, tätig in der Medical - Devices Branche. Der Hauptsitz des Unternehmens ist in Abbott Park, IL, United States. Der aktuelle CEO ist Robert Ford.
ABT hat IPO-Datum 1980-03-17, 114,000 Vollzeitbeschäftigte, gelistet an der NYSE, eine Marktkapitalisierung von $175.63B.
Abbott Laboratories is a global healthcare company founded in 1888 that discovers, develops, manufactures, and sells a broad range of health care products across four primary segments. The Established Pharmaceutical Products segment provides generic medications for conditions including hypertension, dyslipidemia, pain management, and infectious diseases. The Diagnostic Products segment offers laboratory systems, molecular diagnostics, point-of-care testing, and informatics solutions, including rapid COVID-19 and influenza testing. The Nutritional Products segment supplies pediatric and adult nutritional formulations, while the Medical Devices segment manufactures cardiovascular devices, diabetes care products, and neuromodulation systems for chronic pain management. Headquartered in North Chicago, Illinois, Abbott operates worldwide and serves patients, healthcare providers, and consumers across developed and emerging markets.
